Sanofi Wins Approval For New Insulin Drug

February 26, 2015 2:26 AM

14 0

Sanofi SA said late Wednesday it got a green light from U.S. regulators to sell its new insulin product Toujeo, a crucial launch for the French drug maker as it struggles to keep a firm grip on the all-important diabetes market.

Sanofi is counting on Toujeo to help offset sales it will lose when its top-selling drug, the insulin Lantus, loses U.S. patent protection, which is expected later this year.

Read more

To category page